SCHIZOPHRENIA in the midst of a COVID-19 outbreak in a psychiatric hospital in COLOMBIA

Eduardo Rendon-Quintero; Karla Ortiz; Alexie Vallejo Silva

doi:10.1016/j.psychres.2021.113785

SCHIZOPHRENIA in the midst of a COVID-19 outbreak in a psychiatric hospital in COLOMBIA

Producción científica: Contribución a revista › Carta › revisión exhaustiva

Resumen

En el presente documento se describen las características de un grupo de pacientes esquizofrénicos hospitalizados a los que se diagnosticó Cov-2 del SRAS. El número total de pacientes esquizofrénicos con COVID-19 positivo en el momento de esta investigación era de 46. Durante un brote interno en la clínica, todos los pacientes hospitalizados fueron diagnosticados mediante pruebas PCR. La mitad de los pacientes no mostraron síntomas de COVID-19, 22 (47,8%) pacientes padecían enfermedades asociadas, incluyendo hipertensión y dislipidemia, cuatro pacientes tuvieron que ser trasladados a un Hospital General para tratamiento de neumonía, y ninguno de los pacientes requirió tratamiento en UCI. Todos los pacientes se recuperaron. Veinte de los pacientes recibían clozapina como tratamiento antipsicótico.

Idioma original	Inglés estadounidense
Número de artículo	113785
Publicación	Psychiatry Research
Volumen	298
DOI	https://doi.org/10.1016/j.psychres.2021.113785
Estado	Publicada - abr. 2021

ODS de las Naciones Unidas

Este resultado contribuye a los siguientes Objetivos de Desarrollo Sostenible

ODS 3: Salud y bienestar

Áreas temáticas de ASJC Scopus

Psiquiatría y salud mental
Psiquiatría biológica

Acceder al documento

10.1016/j.psychres.2021.113785

Otros archivos y enlaces

Citar esto

@article{c21077b9277c4e38aa5172514c95c842,

title = "SCHIZOPHRENIA in the midst of a COVID-19 outbreak in a psychiatric hospital in COLOMBIA",

abstract = "Herein, the characteristics of a group of hospitalized schizophrenic patients diagnosed with SARS Cov-2 are reported. The total number of COVID-19 positive schizophrenic patients at the time of this investigation was 46. During an internal outbreak in the clinic, all inpatients were diagnosed via PCR tests. Half the patients showed no symptoms of COVID-19, 22 (47.8\%) patients suffered from associated diseases including hypertension and dyslipidemia, four patients had to be transferred to a General Hospital for pneumonia treatment, and none of the patients required ICU treatment. All patients recovered. Twenty of the patients were on clozapine as antipsychotic treatment.",

author = "Eduardo Rendon-Quintero and Karla Ortiz and \{Vallejo Silva\}, Alexie",

note = "Funding Information: We/The authors thank Universidad del Rosario for their support and funding of the manuscript translation and editing. We/The authors thank Crimson Interactive Pvt. Ltd. (Enago) ? https://www.enago.com/es/ for their assistance in manuscript translation and editing Publisher Copyright: {\textcopyright} 2021 Copyright: Copyright 2021 Elsevier B.V., All rights reserved.",

year = "2021",

month = apr,

doi = "10.1016/j.psychres.2021.113785",

language = "English (US)",

volume = "298",

journal = "Psychiatry Research",

issn = "0165-1781",

publisher = "Elsevier Ireland Ltd",

}

TY - JOUR

T1 - SCHIZOPHRENIA in the midst of a COVID-19 outbreak in a psychiatric hospital in COLOMBIA

AU - Rendon-Quintero, Eduardo

AU - Ortiz, Karla

AU - Vallejo Silva, Alexie

N1 - Funding Information: We/The authors thank Universidad del Rosario for their support and funding of the manuscript translation and editing. We/The authors thank Crimson Interactive Pvt. Ltd. (Enago) ? https://www.enago.com/es/ for their assistance in manuscript translation and editing Publisher Copyright: © 2021 Copyright: Copyright 2021 Elsevier B.V., All rights reserved.

PY - 2021/4

Y1 - 2021/4

N2 - Herein, the characteristics of a group of hospitalized schizophrenic patients diagnosed with SARS Cov-2 are reported. The total number of COVID-19 positive schizophrenic patients at the time of this investigation was 46. During an internal outbreak in the clinic, all inpatients were diagnosed via PCR tests. Half the patients showed no symptoms of COVID-19, 22 (47.8%) patients suffered from associated diseases including hypertension and dyslipidemia, four patients had to be transferred to a General Hospital for pneumonia treatment, and none of the patients required ICU treatment. All patients recovered. Twenty of the patients were on clozapine as antipsychotic treatment.

AB - Herein, the characteristics of a group of hospitalized schizophrenic patients diagnosed with SARS Cov-2 are reported. The total number of COVID-19 positive schizophrenic patients at the time of this investigation was 46. During an internal outbreak in the clinic, all inpatients were diagnosed via PCR tests. Half the patients showed no symptoms of COVID-19, 22 (47.8%) patients suffered from associated diseases including hypertension and dyslipidemia, four patients had to be transferred to a General Hospital for pneumonia treatment, and none of the patients required ICU treatment. All patients recovered. Twenty of the patients were on clozapine as antipsychotic treatment.

UR - https://www.scopus.com/pages/publications/85100604635

UR - https://www.scopus.com/pages/publications/85100604635#tab=citedBy

U2 - 10.1016/j.psychres.2021.113785

DO - 10.1016/j.psychres.2021.113785

M3 - Letter

C2 - 33582523

AN - SCOPUS:85100604635

SN - 0165-1781

VL - 298

JO - Psychiatry Research

JF - Psychiatry Research

M1 - 113785

ER -

SCHIZOPHRENIA in the midst of a COVID-19 outbreak in a psychiatric hospital in COLOMBIA

Resumen

ODS de las Naciones Unidas

Áreas temáticas de ASJC Scopus

Acceder al documento

Otros archivos y enlaces

Huella

Citar esto